- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
May 10th, 2007
An Australian biotechnology firm said on Thursday it had developed a means of delivering anti-cancer drugs directly to cancer cells, which aims to avoid the debilitating toxicity associated with chemotherapy.
The method uses nanotechnology, which involves micro-machines far smaller than a human cell.
Direct targeting of chemotherapy drugs would allow dosages thousands of times lower than that in conventional chemotherapy and be more easily tolerated by patients, said the firm.
Writing in the May issue of U.S.-based Cancer Cell magazine, the biotech firm EnGeneIC said it had developed nano-cells containing chemotherapy drugs.
|Related News Press|
Polymeric Nanocarriers Improve Performance of Anticancer Drugs April 30th, 2015
Time Dependant Spectroscopy of Microscopic Samples: CRAIC TimePro™ software is used with CRAIC Technologies microspectrometers to measure the kinetic UV-visible-NIR, Raman and fluorescence spectra of microscopic sample areas May 2nd, 2015
To Conserve London's 300-Year-Old Masterpiece, Nanotech & Drones April 12th, 2015
2015 Nanonics Image Contest January 29th, 2015
OCSiAl supports NanoART Imagery Contest January 23rd, 2015